Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Hyperthermia 1Breast Neoplasms 1

Interventions

Letrozole 26Fulvestrant 25Specimen Handling 20ribociclib 17Paclitaxel 16Capecitabine 16pembrolizumab 15palbociclib 15Trastuzumab 14Carboplatin 14exemestane 13abemaciclib 12Tamoxifen 12Anastrozole 12Magnetic Resonance Spectroscopy 11pertuzumab 9trastuzumab deruxtecan 8Biopsy 8Goserelin 7inavolisib 6giredestrant 6elacestrant 6Radiotherapy 6Cyclophosphamide 6130-nm albumin-bound paclitaxel 6patritumab deruxtecan 5eribulin 5Taxes 5Standard of Care 5Gonadotropin-Releasing Hormone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × AC protocol × 30 days × Clear all
NCT05889390 2026-05-15

NeoHTerMa

Semmelweis University

Phase 2/3 Active not recruiting
71 enrolled
Breast

Hyperthermia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡